Features

The Features section includes articles on topics, events, people, and initiatives of interest to the oncology community.

Mar 08, 2021
First YIA recipient Dr. Judith Kaur looks to the future with Conquer Cancer Board chair Dr. Howard A. “Skip” Burris III.
Mar 08, 2021
From children to seniors, Conquer Cancer, the ASCO Foundation, funds researchers around the world, helping patients with cancer at every age.
Mar 08, 2021
The American Board of Internal Medicine (ABIM) Board of Directors has announced it will extend all Maintenance of Certification (MOC) requirement deadlines through December 31, 2022.
Mar 07, 2021
Journalist Craig Melvin and Conquer Cancer researcher Dr. Kimmie Ng discuss the troubling increase of young-onset colorectal cancer, and advocate for screening and awareness.
Mar 07, 2021
Conquer Cancer is increasing grant and award opportunities to expand equitable clinical trial access for patients, and continues raising funds for research and education resources to support ASCO’s commitment to equitable health care.
Mar 04, 2021
Dr. Sherilyn Tuazon is innovating new approaches to autologous stem cell transplant (ASCT) treatment for patients with multiple myeloma.
Mar 04, 2021
“Our careers have honored the lives of our patients, and it’s a part of our legacy we want to continue,” said Dr. Frank Ferris. “We chose Conquer Cancer because of ASCO’s commitment to changing the lives of patients and families through education domestically and internationally.”
Mar 04, 2021
On March 4, a meeting of the Lancet Oncology Commission on Medical and Nuclear Imaging, of which ASCO is a part, took place as part of the European Congress of Radiology (ECR) 2021.
Feb 12, 2021
Much of the progress of the past 5 decades was catalyzed by the National Cancer Act, signed into law by President Richard Nixon in December 1971.
Jan 15, 2021
A new special series includes guidance on factors and decision-making processes for selecting the right platform, how to reduce expenses from manual burdens, and how to allocate resources to successfully enable NGS for clinical cancer care. 

Pages